<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2601">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on February 08, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04641195</url>
  </required_header>
  <id_info>
    <org_study_id>VR3- 172649</org_study_id>
    <nct_id>NCT04641195</nct_id>
  </id_info>
  <brief_title>Vitamin D and Zinc Supplementation for Improving Treatment Outcomes Among COVID-19 Patients in India</brief_title>
  <official_title>A Randomized Trial to Determine the Effect of Vitamin D and Zinc Supplementation for Improving Treatment Outcomes Among COVID-19 Patients in India</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Harvard School of Public Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Foundation for Medical Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Health Network, Toronto</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Harvard School of Public Health</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess the effect of vitamin D and/or zinc supplementation on&#xD;
      improving COVID-19 treatment outcomes. The effects of vitamin D, zinc, and both vitamin D and&#xD;
      zinc together will be investigated among COVID-19 patients in India.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is a 2x2 factorial randomized double-blind, placebo-controlled trial to examine&#xD;
      the effectiveness of vitamin D and zinc supplements as immune-based therapy among COVID-19&#xD;
      patients in India. The study is also examining the immunological response to COVID-19 and the&#xD;
      effect of the intervention on specific biomarkers of immune and endothelial activation that&#xD;
      are independent and quantitative predictors of severity and mortality in other severe&#xD;
      infections. The primary aims are to determine the effect of vitamin D supplementation versus&#xD;
      placebo on time to recovery among patients hospitalized with COVID-19; and to determine the&#xD;
      effect of zinc supplementation versus placebo on time to recovery among patients hospitalized&#xD;
      with COVID-19. As secondary aims, this study is also investigating the effect of vitamin D or&#xD;
      zinc supplementation on all-cause mortality. necessity for assisted ventilation, individual&#xD;
      symptoms duration and biomarkers including vitamin D, Zinc, Interleukin 6 (IL-6),&#xD;
      Angiopoietin-2, sTREM-1, immunoglobulin G (IgG) and immunoglobulin M (IgM).&#xD;
&#xD;
      Eligible individuals are randomly assigned to one of four groups: (1) Vitamin D (180,000 IU&#xD;
      bolus at enrollment, followed by 2000 IU daily); (2) Zinc (placebo at enrollment followed by&#xD;
      one daily dose of 40 mg); (3) Vitamin D and Zinc; or (4) Placebo. Daily supplements start at&#xD;
      the hospital and continue after discharge for a total of 8 weeks. Active data collection&#xD;
      occurs daily while patients are hospitalized and at least twice per week via telephone after&#xD;
      discharge. A clinical exam occurs at the hospital at 8 weeks and longer-term symptoms are&#xD;
      assessed at 3 months.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 7, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">August 31, 2021</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <intervention_model_description>The effect of both interventions (vitamin D or zinc) will be investigated simultaneously using a factorial design.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to recovery</measure>
    <time_frame>Up to 8 weeks</time_frame>
    <description>Defined as resolution of fever, cough and shortness of breath relative to baseline</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>All-cause mortality</measure>
    <time_frame>Up to 8 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Necessity for assisted ventilation</measure>
    <time_frame>Up to 8 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Individual symptoms duration</measure>
    <time_frame>Up to 8 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vitamin D</measure>
    <time_frame>At 8 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Zinc</measure>
    <time_frame>At 8 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Interleukin 6 (IL-6)</measure>
    <time_frame>At 8 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Angiopoietin-2</measure>
    <time_frame>At 8 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>sTREM-1</measure>
    <time_frame>At 8 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Immunoglobulin M (IgM)</measure>
    <time_frame>At 8 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Immunoglobulin (IgG)</measure>
    <time_frame>At 8 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">700</enrollment>
  <condition>COVID-19</condition>
  <arm_group>
    <arm_group_label>Placebo- Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Participants in the PLACEBO-PLACEBO group will receive a placebo vitamin D bolus at the hospital followed by placebo daily vitamin D maintenance doses and placebo daily zinc supplements.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vitamin D- Placebo</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in the VITAMIN D-PLACEBO group will receive an actual vitamin D bolus at the hospital followed by actual daily vitamin D maintenance doses and daily placebo zinc supplements.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo-Zinc</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in the PLACEBO-ZINC group will receive a placebo vitamin D bolus at the hospital followed by placebo daily vitamin D maintenance doses and actual daily zinc supplements.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Vitamin D- Zinc</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in the VITAMIN D-ZINC group will receive an actual vitamin D bolus at the hospital followed by actual daily vitamin D maintenance doses and actual daily zinc supplements.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Vitamin D3 (cholecalciferol)</intervention_name>
    <description>180,000 international units (IU) of vitamin D3 at enrollment, followed by 2000 IU once per day from enrollment to 8 weeks</description>
    <arm_group_label>Vitamin D- Placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Zinc (zinc gluconate)</intervention_name>
    <description>40mg of zinc gluconate taken once per day from enrollment to 8 weeks</description>
    <arm_group_label>Placebo-Zinc</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Zinc (zinc gluconate) &amp; Vitamin D (cholecalciferol)</intervention_name>
    <description>180,000 IU of vitamin D3 at enrollment, followed by 2000 IU of vitamin D3 and 40mg of zinc gluconate once per day from enrollment to 8 weeks</description>
    <arm_group_label>Vitamin D- Zinc</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo vitamin D bolus at enrollment followed by placebo daily vitamin D maintenance doses and placebo daily zinc supplements.</description>
    <arm_group_label>Placebo- Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Aged &gt;=18 years old&#xD;
&#xD;
          -  Polymerase chain reaction (PCR)-confirmed infection with SARS-COV2&#xD;
&#xD;
          -  Oxygen saturation level of 90 or above&#xD;
&#xD;
          -  Provide informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Enrollment in other clinical trials&#xD;
&#xD;
          -  Daily use of multivitamins for the past 1 month&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wafaie W Wafaie, MBBS, MPH, MS, DrPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Harvard School of Public Health</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Wafaie W Fawzi, MBBS, MPH, MS, DrPH</last_name>
    <phone>617 432 2086</phone>
    <email>mina@hsph.harvard.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kevin Kain, MD</last_name>
    <email>Kevin.Kain@uhn.ca</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Saifee Hospital</name>
      <address>
        <city>Mumbai</city>
        <state>Maharashtra</state>
        <country>India</country>
      </address>
    </facility>
    <contact>
      <last_name>Guaray Gupta, MD</last_name>
      <phone>+91 9867220473</phone>
      <email>dr.gauravgupta@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>King Edward Memorial (KEM) Hospital</name>
      <address>
        <city>Pune</city>
        <state>Maharashtra</state>
        <country>India</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>November 19, 2020</study_first_submitted>
  <study_first_submitted_qc>November 20, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 23, 2020</study_first_posted>
  <last_update_submitted>November 20, 2020</last_update_submitted>
  <last_update_submitted_qc>November 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 23, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Harvard School of Public Health</investigator_affiliation>
    <investigator_full_name>Wafaie Fawzi</investigator_full_name>
    <investigator_title>Professor of Nutrition, Epidemiology, and Global Health</investigator_title>
  </responsible_party>
  <keyword>COVID-19</keyword>
  <keyword>Vitamin-D3</keyword>
  <keyword>Zinc</keyword>
  <keyword>Nutrition support</keyword>
  <keyword>Host-directed therapy</keyword>
  <keyword>Clinical management</keyword>
  <keyword>India</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Cholecalciferol</mesh_term>
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Zinc</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

